NEW research has shown that anti-CGRP monoclonal antibodies (mAbs) are not associated with an increased cardiovascular ...

Novel antibodies have the potential to pave the way for the next generation of malaria interventions. Researchers at the ...

Windward Bio has landed with a flurry of announcements, circling in a $200 million series A and offering up to $970 million ...

The therapy showed a ‘favourable’ safety profile both as a single agent and in combination with standard-of-care treatment.

A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new ...

Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, ...

Transaction Expands Climb Bio’s Pipeline of B-cell Targeted Therapeutics to Address Immune-mediated Diseases New Program is a ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to GSK5764227 (GSK’227) for the treatment of adult patients with relapsed or refractory (R/R) osteosarcoma who have ...